Pyogenic infections in Eastern Nepal with special reference to Staphylococcus aureus
Keywords:
methicillin resistance Staphylococcus aureus, multi-drug resistance, pyogenic infection, Staphylococcus aureusAbstract
Introduction: Pyogenic infections are significant clinical condition associated with wide variety of pyogenic bacteria, predominantly Staphylococcus aureus. A rising trend of multi-drug resistance pathogens, in particular methicillin resistant Staphylococcus aureus (MRSA) are reported with pyogenic infections globally. It is important to identify the microbial pathogen for rapid institution of optimal antimicrobial agent in early stage to overcome the life threatening complications. This study was planned to determine the clinically significant bacterial profile of pyogenic infection special reference to Staphylococcus aureus and its antimicrobial susceptibility pattern.
Methods: A Descriptive cross-sectional study was conducted at B. P. Koirala Institute of Health Sciences. Wound swabs and pus aspirates were collected from each patient suspecting pyogenic infection. Following standard microbiological methods, isolation and identification was done in the Department of Microbiology. Antimicrobial susceptibility test along with MRSA detection was performed following Clinical and Laboratory Standard Institute.
Results: Of the 1863 specimens, culture was positive in 50.8% of cases. Staphylococcus aureus (39.5%) was the leading cause of pyogenic infection followed by Escherichia coli (12.2%), Acinetobacter baumani complex (10.1%). Staphylococcus aureus was sensitive to vancomycin (100%), linezolid (100%), amikacin (79.70%), cotrimoxazole (77.60%), gentamicin (64.53%), ciprofloxacin (46.06%), cefalexin (37.6%), ceftriaxone (34.66%), erythromycin (27.46%), penicillin (6.66%), cefoxitin (37.86%). Staphylococcus aureus was multidrug resistant with methicillin resistant rate of 51.2 %.
Conclusion: Pyogenic wound infections predominantely caused by high rates of methicillin resistance Staphylococcus aureus with multiple drug resistance is highly alarming. Therefore, continuous surveillance should be done to update the resistance pattern and guide rational use of antibiotics.
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Copyright and Open Access Policy
This journal provides immediate open access to its content on the principle that making research freely available to the public supports a greater global exchange of knowledge.
JKISTMC applies the Creative Commons Attribution (CC BY) license to all works we publish. Under the CC BY license, authors retain ownership of the copyright for their article, but authors allow anyone to download, reuse, reprint, distribute, and/or copy articles in JKISTMC, so long as the original authors and source are cited. No permission is required from the authors or the publishers.